#United States #Boston #New England Biolabs #NEBNext #AMP 2025

New England Biolabs at AMP 2025: Revolutionizing Molecular Diagnostics

New England Biolabs (NEB), a front-runner in enzyme technologies and molecular biology solutions, is set to make a significant impact at the AMP 2025 Annual Meeting and Expo in Boston, Massachusetts. Scheduled for November 11–15, 2025, this event will showcase NEB's dedication to advancing molecular diagnostics and infectious disease surveillance.

Andrew Barry, Associate Director of Portfolio Management for Next Generation Sequencing at NEB, shared, "We are excited to engage with the AMP community and illustrate how our enzyme engineering and assay development expertise is aiding scientists in confronting global health challenges."

During the conference, NEB will conduct two essential corporate workshops on November 12. The first workshop, set for 9:00 AM, will spotlight a real-world application of NEBNext reagents in a critical diagnostics workflow. Dr. Harrison Tsai, an expert from Brigham and Women's Hospital, will present, "NEB bespoke solutions collaborating on a custom NGS rapid heme panel to serve the Boston community." This workshop illustrates NEB's commitment to practical solutions that address pressing health issues in local hospitals.

Following this, at 10:00 AM, Dr. Nichole Nichols, Executive Director of Application Product Development at NEB, will lead the second workshop. Titled "Behind the Catalog: NEB Capabilities Shaping the Science of Tomorrow," this session will delve into various ways NEBNext reagents empower researchers to tackle challenges in infectious disease surveillance and oncology assays, showcasing recent real-world successes.

Additionally, the Innovation Spotlight is scheduled for November 13 at 4:25 PM, where Nathan Tanner, Associate Director of Research, will present "Powering the Next Generation of Diagnostics with Enzyme Engineering and Design." This session aims to illuminate the future landscape of diagnostics enabled by enzyme innovation.

Moreover, NEB scientists will exhibit three scientific posters that reflect their ongoing research:

1. High-throughput Methyl-binding Domain-based DNA Enrichment and Sequencing – Presented by Dr. Kaylinnette Pinet.
2. Integration of Whole-exome Sequencing and RNA-seq Facilitates Somatic Mutation Detection in Tumor Tissue Samples – Presented by Dr. Margaret R. Heider.
3. NEBNext Enzymatic Solutions for DNA Methylation Profiling of Highly Damaged DNA Inputs – Presented by Dr. Vaishnavi Panchapakesa.

Interactive Engagement

During the event, scientists and researchers will have the opportunity to engage with NEB's local Account Management and Customized Solutions Teams, who will be readily available to discuss how NEB can support various research and assay development needs.

About New England Biolabs

For over half a century, New England Biolabs has been at the forefront of producing innovative products tailored for molecular biology research. Their dedication to scientific discovery extends to investing in their product portfolio, supporting customer research in academia and industry, and pioneering technologies for molecular diagnostics and vaccine development. NEB, a privately held company headquartered in Ipswich, Massachusetts, maintains a global presence with subsidiary offices in ten countries, and over sixty distribution partners worldwide. To learn more about NEB's offerings and initiatives, visit www.neb.com.

With the AMP 2025 Annual Meeting, New England Biolabs continues to exemplify its commitment to advancing science and improving health outcomes for communities everywhere.